• OPEN AN ACCOUNT
Indian Indices
Nifty
25,145.50 -81.85
(-0.32%)
Sensex
82,029.98 -297.07
( -0.36%)
Bank Nifty
56,496.45 -128.55
( -0.23%)
Nifty IT
35,214.85 -115.95
( -0.33%)
Global Indices
Nasdaq
46,310.43 221.84
(0.48%)
Dow Jones
6,668.02 -7.70
(-0.12%)
Hang Seng
46,768.58 -1,320.22
(-2.75%)
Nikkei 225
9,452.77 9.90
(0.10%)
Forex
USD-INR
88.75 -0.06
(-0.07%)
EUR-INR
103.09 0.08
(0.07%)
GBP-INR
118.50 -0.08
(-0.06%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
868.316327
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
28.52
53443.19
EPS(TTM)
Face Value()
Div & Yield %
66.4
1
0.13
 

SEPC gains after securing engineering services contract from Avenir International
Sep 29,2025

The total value of the contract stands at AED 13.5 million, which translates to approximately Rs 32.63 crore at prevailing exchange rates.

The sub-contract entails the performance of a wide range of engineering services, marking a significant step forward in SEPC’s presence in the Middle East’s energy infrastructure space. Specific schedules and project timelines will be communicated by the counterparty in due course and will align with ADNOC’s operational requirements.

The award of this contract underscores SEPC’s growing international engagement and its capabilities in delivering high-value engineering solutions for global clients.

SEPC has clarified that the awarding entity, Avenir International Engineers and Consultants LLC, is an unrelated international party, with no connection to the company's promoter, promoter group, or group companies. Accordingly, the transaction does not fall within the scope of related party transactions.

SEPC is engaged in providing end-to-end solutions to engineering challenges, offering multidisciplinary design, engineering, procurement, construction, and project management services.

The company’s consolidated net profit surged 104.8% YoY to Rs 16.55 crore in Q1 FY26, compared to Rs 8.08 crore in the year-ago quarter. Revenue from operations rose 15% YoY to Rs 202.28 crore from Rs 175.82 crore in Q1 FY25.